Maximal androgen blockade (MAS) for the treatment of prostate cancer

被引：0
|
作者：
Kirby, RS
机构：
来源：
BRITISH JOURNAL OF CLINICAL PRACTICE | 1996年 / 50卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：287 / 287
页数：1
相关论文
共 50 条
  • [21] TOTAL ANDROGEN BLOCKADE FOR METASTATIC CANCER OF PROSTATE
    BELAND, G
    ELHILALLI, MM
    FRADET, Y
    LAROCHE, B
    RAMSEY, EW
    TRACHTENBERG, J
    VENNER, PN
    JOURNAL OF UROLOGY, 1987, 137 (04): : A254 - A254
  • [22] Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer
    Galvao, Daniel A.
    Spry, Nigel A.
    Taaffe, Dennis R.
    Newton, Robert U.
    Stanley, John
    Shannon, Tom
    Rowling, Chris
    Prince, Richard
    BJU INTERNATIONAL, 2008, 102 (01) : 44 - 47
  • [23] Continuous versus six months a year maximal androgen blockade in the management of prostate cancer:: A randomised study
    Irani, Jacques
    Celhay, Olivier
    Hubert, Jacques
    Bladou, Franck
    Ragni, Evelyne
    Trape, Gerard
    Dore, Bertrand
    EUROPEAN UROLOGY, 2008, 54 (02) : 382 - 391
  • [24] Comparison of maximal and more maximal intermittent androgen blockade during 5-year treatment of advanced prostate cancer T3NxMx-1
    Slawomir A. Dutkiewicz
    International Urology and Nephrology, 2012, 44 : 487 - 492
  • [25] Comparison of maximal and more maximal intermittent androgen blockade during 5-year treatment of advanced prostate cancer T3NxMx-1
    Dutkiewicz, Slawomir A.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2012, 44 (02) : 487 - 492
  • [26] Telomerase as an important target of androgen-signaling blockade for prostate cancer treatment
    Liu, Shuang
    Qi, Yanfeng
    Ge, Yubin
    Duplessis, Tamika
    Rowan, Brian G.
    Cheng, Helen
    Rennie, Paul S.
    Zhang, Haitao
    Dong, Yan
    CANCER RESEARCH, 2010, 70
  • [27] REVIEW OF ASSESSMENT OF TOTAL ANDROGEN BLOCKADE AS TREATMENT OF METASTATIC PROSTATE-CANCER
    GELLER, J
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1991, 14 (10) : 881 - 891
  • [28] Telomerase as an important target of androgen-signaling blockade for prostate cancer treatment
    Liu, Shuang
    Qi, Yanfeng
    Ge, Yubin
    Duplessis, Tamika
    Rowan, Brian G.
    Cheng, Helen
    Rennie, Paul S.
    Zhang, Haitao
    Dong, Yan
    CANCER RESEARCH, 2010, 70
  • [29] Combined androgen blockade is the treatment of choice for patients with advanced prostate cancer: The argument for
    Debruyne, FMJ
    EUROPEAN UROLOGY, 1996, 29 : 34 - 36
  • [30] CTLA-4 BLOCKADE WITH ANDROGEN DEPRIVATION AND RADIOTHERAPY FOR THE TREATMENT OF PROSTATE CANCER
    Blood, P. A.
    Johnson, L. D. S.
    Beckham, W. A.
    Russell, G.
    Pai, H. H.
    Lim, J. T.
    Richier, L. R.
    Nelson, B. H.
    Vlachaki, M. T.
    Lum, J. J.
    RADIOTHERAPY AND ONCOLOGY, 2012, 104 : 35 - 35
12345